• Fri, April 4, 2025

2 cannabis stocks to sell, 1 contrarian buy: Tilray, Canopy Growth, Curaleaf

This article highlights two cannabis stocks to sell, and one potential contrarian buy to buy. Names are Tilray, Canopy, and Curaleaf.
The article from Invezz, published on April 4, 2025, discusses the performance and future prospects of three cannabis companies: Tilray Brands, Canopy Growth, and Curaleaf Holdings. It advises investors to sell Tilray Brands and Canopy Growth due to their ongoing struggles with profitability and declining stock prices, despite the potential growth in the cannabis industry. Tilray has been unable to turn a profit consistently, and Canopy Growth has seen its stock value plummet significantly. In contrast, the article suggests buying Curaleaf Holdings as a contrarian investment, citing its strong market position in the U.S., where it has a significant presence in multiple states, and its potential for growth as more states legalize cannabis. Curaleaf's focus on both medical and recreational markets, along with its strategic acquisitions, positions it well for future success.

Read the Full Invezz Article at:
https://invezz.com/news/2025/04/04/2-cannabis-stocks-to-sell-1-contrarian-to-buy-tilray-canopy-growth-curaleaf/

Like: 👍